Merging our Strengths: Vesper Medical acquired by Philips to expand its therapeutic devices portfolio Read More

Press Release

Vesper Medical Announces Completion of Enrollment in the VIVID Clinical Trial

Company Achieves Key Milestone in the Development of its Next Generation Deep Venous Stent System Wayne, PA, December 20, 2021 –Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced the completion of enrollment in its pivotal study – Venous stent for the Iliofemoral Vein Investigational clinical trial using the Vesper …

Vesper Medical Announces Completion of Enrollment in the VIVID Clinical Trial Read More »

Stacy Enxing Seng Joins the Vesper Medical Board of Directors

Wayne, PA, January 4, 2021 Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced that Stacy Enxing Seng has joined the board of directors effective immediately. An accomplished executive leader, Stacy has over 25 years in sales, marketing and operational leadership roles building innovative technology portfolios, demonstrated clinical outcomes, exceptional …

Stacy Enxing Seng Joins the Vesper Medical Board of Directors Read More »

Vesper Medical Announces First Enrollment in the VIVID Trial

Malvern, PA, December 1, 2020 Vesper Medical, Inc., a developer of medical devices for deep venous disease, today announced initiation of its U.S. Food and Drug Administration (FDA) Investigational Exemption (IDE) study – Venous stent for the Iliofemoral Vein Investigational clinical trial using the Vesper DUO Venous Stent System® (VIVID). The VIVID Trial, which enrolled

Scroll to Top
Scroll to Top